Fusion Antibodies plc (FAB.L) Diversifiers

Equity · Currency in GBp · Last updated Jun 6, 2026

Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. The company offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. It serves pharmaceutical, biotech, and diagnostic companies. The company has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.

Looking to balance out your exposure to FAB.L? The ETFs below have the lowest correlation with FAB.L — they tend to move on their own, which can help reduce risk when FAB.L drops. The stock ideas table highlights individual companies that behave independently from FAB.L.

No Diversifiers Found for FAB.L

We do not have enough correlation history to rank diversifiers for this symbol yet.

Diversification Analysis

Build a portfolio that complements FAB.L

Add FAB.L to the Diversification Analyzer to see how it overlaps with your other holdings and which assets balance it best.

Analyze a portfolio with FAB.L